NU# [001]

Related by string. NU# [002] * * NU# direct . NU# 1ST DOWN *

Related by context. Frequent words. (Click for all words.) 63 AP# [003] 62 HGS ETR1 62 HspE7 60 ISIS # 60 MDV# 60 NGX# 60 TREANDA 59 INCB# [002] 59 Phase Ib 59 IDX# 58 MultiStem 58 MGCD# [001] 58 RDEA# 58 pralatrexate 58 Debio 58 Marqibo 58 Phase 1b 58 Phase 2a trial 58 BAY #-# 58 PRX # 58 IMGN# 58 pharmacokinetic profile 57 TRIOLEX 57 alfimeprase 57 sapacitabine 57 CTCE 57 XL# [003] 57 Phase 2b study 57 CoFactor 57 PF # [001] 57 ADVEXIN 57 GRN#L 57 ZYBRESTAT 57 AZD# 57 HE# [002] 56 elesclomol 56 Azixa 56 eltrombopag 56 Phase IIa trial 56 Phase 2a 56 Zerenex 56 CA4P 56 dose escalation trial 56 Phase 2b trial 56 ALN RSV# 56 MLN# 56 RG# [001] 56 Phase IIa clinical 56 LymphoStat B 56 belinostat 56 eculizumab 55 JAK2 55 ALN VSP 55 perifosine 55 castration resistant prostate cancer 55 tamibarotene 55 clofarabine 55 Phase IIb clinical 55 multiple ascending dose 55 PLX# 55 pharmacodynamic 55 Stimuvax 55 phase IIb 55 humanized monoclonal antibody 55 daclizumab 55 IND enabling 55 Phase 2a clinical 55 CYT# 55 ONCONASE 54 APD# 54 ANAVEX #-# [003] 54 Albuferon 54 antisense drug 54 vilazodone 54 antitumor activity 54 mAb 54 Phase IIa 54 epratuzumab 54 INGN 54 denufosol 54 selective inhibitor 54 CRx 54 BiTE antibody 54 Perifosine 54 laquinimod 54 ENMD 53 mipomersen 53 hematological cancers 53 MB# [004] 53 Atiprimod 53 Preclinical studies 53 preclinical studies 53 ARRY 53 TNFerade 53 lupus nephritis 53 immunomodulatory 53 antiviral activity 53 GATTEX 53 ALKS 53 CK # 53 AEZS

Back to home page